KRW 1685.0
(3.44%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -19.26 Billion KRW | 21.7% |
2022 | -24.59 Billion KRW | 29.05% |
2021 | -34.67 Billion KRW | -204.72% |
2020 | 33.1 Billion KRW | 461.36% |
2019 | -9.16 Billion KRW | -60.05% |
2018 | -5.72 Billion KRW | 16.06% |
2017 | -6.81 Billion KRW | 24.76% |
2016 | -9.06 Billion KRW | -127.63% |
2015 | -3.98 Billion KRW | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -3.23 Billion KRW | 4.71% |
2024 Q2 | -4.05 Billion KRW | -25.38% |
2023 Q1 | -6.13 Billion KRW | -71.87% |
2023 Q3 | -3.56 Billion KRW | 42.16% |
2023 Q4 | -3.39 Billion KRW | 4.83% |
2023 Q2 | -6.16 Billion KRW | -0.46% |
2023 FY | -19.26 Billion KRW | 21.7% |
2022 Q2 | -9.93 Billion KRW | -53.01% |
2022 FY | -24.59 Billion KRW | 29.05% |
2022 Q4 | -3.57 Billion KRW | 22.31% |
2022 Q3 | -4.59 Billion KRW | 53.75% |
2022 Q1 | -6.49 Billion KRW | 33.74% |
2021 FY | -34.67 Billion KRW | -204.72% |
2021 Q2 | 6.94 Billion KRW | 129.33% |
2021 Q3 | -8.12 Billion KRW | -216.97% |
2021 Q4 | -9.8 Billion KRW | -20.59% |
2021 Q1 | -23.68 Billion KRW | -166.51% |
2020 Q1 | -2.9 Billion KRW | 39.86% |
2020 FY | 33.1 Billion KRW | 461.36% |
2020 Q4 | 35.61 Billion KRW | 3704.16% |
2020 Q3 | 936.32 Million KRW | 271.53% |
2020 Q2 | -545.86 Million KRW | 81.19% |
2019 FY | -9.16 Billion KRW | -60.05% |
2019 Q4 | -4.82 Billion KRW | -209.53% |
2019 Q3 | -1.55 Billion KRW | 0.0% |
2018 FY | -5.72 Billion KRW | 16.06% |
2017 FY | -6.81 Billion KRW | 24.76% |
2016 FY | -9.06 Billion KRW | -127.63% |
2015 FY | -3.98 Billion KRW | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 116.43 Billion KRW | 116.541% |
InBody Co.,Ltd | 36.72 Billion KRW | 152.447% |
Curexo Inc. | -4.85 Billion KRW | -296.622% |
Seegene, Inc. | 669.01 Million KRW | 2978.876% |
i-SENS, Inc. | 3.7 Billion KRW | 619.269% |
Ray Co., Ltd. | -2.14 Billion KRW | -797.351% |
Sugentech Inc. | -17.23 Billion KRW | -11.728% |
L&C Bio Co., Ltd | 48.36 Billion KRW | 139.826% |